Overview
This single-day program will consist of lectures and case discussions highlighting a multidisciplinary approach to the management of urologic disease with the integration of new technology in the evaluation and treatment of patients. Evidence-based medicine highlighting relevant clinical trial data will be provided as well as focusing on current controversies in prostate cancer, urologic malignancies, and the management of benign conditions.
Topics include the latest in shared decision making in prostate cancer, developments in treatment for advanced prostate cancer, the importance of prehabilitation in MIBC prior to cystectomy, new treatments for BCG Unresponsive NMIBC, novel treatments for urinary incontinence, male infertility updates, management of intraoperative complications, and pediatric urology update as well as discussions on leadership skills and female urologists.
Date & Location
Friday, August 23rd, 2024, 7:45 AM - 4:30 PM, Samis Education Center, 1200 Children's Ave, Oklahoma City, OK
Target Audience
Urologists, Primary Care Physicians, Specialty Physicians, Oncologists, Radiation Oncologists, Related Physician Assistants, Nurses, Nurse Practitioners, Navigators, and other Administrative Staff Supporting Oncology Programs.
Objectives
- Describe the role of MRI, Micro-ultrasound, and PSMA PET imaging in clinical management of prostate cancer.
- Improve knowledge of medical and surgical management of nephrolithiasis.
- Improve knowledge of evolving concepts in the management of upper tract tumors.
Registration
Registration for Attendees - The registration fee is complimentary, but registration is required. A virtual option is not available.
For more information or if you have questions, please contact Holly Weldon - at 405-271-2140 or holly-weldon@ouhsc.edu
Please contact Holly Weldon at holly-weldon@ouhsc.edu or (405)271-2140
Keynote Speakers
Dr. Jeffrey Holzbeierlein - A physician in chief at The University of Kansas Cancer Center and the William L. Valk Endowed Professor at the University of Kansas Medical Center.
Dr. Laura Martinez - A urology specialist at Houston Methodist Urology Associates and an instructor at Academic Institute
Houston Methodist Weill Cornell Medical College.
Program Agenda
Friday, August 23rd | 6:30 AM - 4:00 PM
|
6:30 AM
|
BREAKFAST & EXHIBITS
|
|
|
7:35 AM
|
Introduction & Welcome
|
Kelly Stratton, MD
|
|
7:45 AM
|
Shared Decision Making in Prostate Cancer
|
Jonathan Heinlen, MD
|
|
8:00 AM
|
Prostate Biopsy Techniques
|
Andrew McIntosh, MD
|
|
8:15 AM
|
Single Port Robotic Surgery
|
Mohammad Ramadan, MD
|
|
8:30 AM
|
Panel Discussion: Prostate Cancer
|
Moderator: Kelly Stratton, MD
Panelists: Mohammad Ramadan, MD; Jared Higley, MD; Andrew Jensen, MD
|
|
9:00 AM
|
Results from the S1600 Trial in Bladder Cancer
|
Jeffrey Holzbeierlein, MD
|
|
9:30 AM
|
BCG Unresponsive NMIBC
|
Sanjay Patel, MD
|
|
9:45 AM
|
What’s new in Invasive Bladder Cancer
|
Adanma Ayanambakkam, MD
|
|
10:00 AM
|
Panel Discussion: Bladder Cancer
|
Moderator: Sanjay Patel, MD
Panelists: Brian Cross, MD; Andrew McIntosh, MD; Adanma Ayanambakkam, MD; Jeffrey Holzbeierlein, MD
|
|
10:30 AM
|
BREAK & EXHIBITS
|
|
|
11:00 AM
|
Treatment Intensification: mHSPC
|
Michael Cookson, MD
|
|
11:15 AM
|
Managing Intraoperative Complications in Urologic Oncology
|
Brian Cross, MD
|
|
11:30 AM
|
Lessons in Leadership
|
Jeffrey Holzbeierlein, MD
|
|
12:00 PM
|
LUNCH & EXHIBITS
|
|
|
1:00 PM
|
Overview of Afternoon and Introductions
|
James Furr, MD
|
|
1:30 PM
|
Game Changers in Urinary Incontinence
|
Laura Martinez, MD
|
|
1:45 PM
|
Evaluation of the Infertile Male
|
Johnathan Doolittle, MD
|
|
2:00 PM
|
Urethral Stricture Disease Update
|
James Furr, MD
|
|
2:30 PM
|
Panel Discussion: Neuro-Urology
|
Moderator: Gennady Slobodov, MD
Panelists: Laura Martinez, MD; Katy Cunningham, MD; Kristy Nguyen, MD
|
|
3:00 PM
|
Women in Urology: Closing the Gap
|
Laura Martinez, MD
|
|
3:15 PM
|
Resident Case Presentations: Four 8 min presentations T-Leon Howard style, prize for winner
|
Erin Crane, PGY3; Avery Wolfe, PGY3; Brennan Lee, PGY4; Nate Alder, PGY5
|
|
3:45-4:00 PM
|
Closing Remarks Q&A
|
Michael Cookson, MD
|
Accreditation
The University of Oklahoma Health Science
2024 Oklahoma Urologic Symposium
August 23, 2024
Oklahoma City, OK
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and The University of Oklahoma Heath Science. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP.
Physician Assistants
PAs may claim a maximum of 6.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.